The Association of the British Pharmaceutical Industry also disapproves. "Programmes have been established to allow patients in the poorest economies to benefit from innovations such as curative treatments for hepatitis C," a spokesman said.
"When these arrangements are misused to redirect supply, it undermines the availability of health treatments for the poorest people in the world, and undermines the incentives for innovation that will lead us to the next treatments."
Total bollocks!!! Manufacturers of generic drugs can and do manufacture enough drugs to meet supply. The formula for these drugs is not mysterious, nor are the raw materials for them in short supply.
And 'incentives for innovation'? Err....is the twenty-odd BILLION Dollars that gilead have made so far from Sovaldi and Harvoni enough incentive to go forward?